Allergy Diagnostics Market to Rise at a 11.1% CAGR from 2021 to 2026

 

The Allergy Diagnostics Market is projected to reach USD 8.2 billion by 2026 from USD 4.8 billion in 2021, at a CAGR of 11.1% from 2021 to 2026. Factors such as, rising environmental pollution levels, high incidence of allergic diseases, increasing funds by organizations in allergy diagnostics are anticipated to drive growth of the allergy diagnostics market.

Get Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=232871701

Key Market Players:

Thermo Fisher Scientific Inc., (US), Siemens Healthineers (Germany), Danaher (US), Omega Diagnostics Group PLC (UK), bioMérieux SA (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), NEOGEN Corporation (US), Eurofins Scientific (Luxembourg), Minaris Medical America, Inc. (US), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), and Erba Group (UK).

Market Dynamics

DRIVER: Rising environmental pollution levels

Exposure to indoor and outdoor air pollutants, allergens, and occupational exposure are the major risk factors causing chronic respiratory diseases. The prevalence of allergic disorders among the urban population is higher than those living in rural areas due to the higher exposure to environmental pollutants in cities (as a result of vehicular pollution and industrial activities).

As per the WHO, more than 80% of people living in urban areas are exposed to air quality levels that exceed the WHO safety limits; though this is a global trend, its effects are more severe in the urban areas of low-income countries. This is a major indicator for the growth of the allergy diagnostics market, as air pollution from motor vehicles has been indicated as one of the major risk factors responsible for allergic diseases.

Epidemiological and toxicological research reveals a causal relationship between air pollution and the increased incidence of asthma, allergic rhinitis, and other allergic disorders. Studies have also demonstrated a significant increase in the incidence and exacerbation of asthma in urban locations with elevated PM 2.5 (particulate matter of size 2.5 micrometers or less), nitrogen dioxide, and ozone concentrations.

OPPORTUNITY: Use of mHealth in allergy diagnosis

The use of mHealth for the diagnosis of rhinitis is currently limited, with a small number of mHealth tools for allergic rhinitis (AR) diagnosis published in peer-reviewed journals. Recent developments in integrated biosensors, wireless communication, and power harvesting techniques generate a new breed of point-of-care devices. However, AR is a very common disease. Any diagnostic device connected to a smartphone (e.g., peak nasal inspiratory flow meters or intranasal biosensors) would need to be inexpensive to be affordable.

The monitoring of the control of allergic multimorbidity (rhinitis, conjunctivitis, and asthma) has been approached by several apps. Allergymonitor, for example, helps in monitoring the symptoms and medication intake, which is then matched to local pollen concentrations. Similarly, the MASK (Mobile Airways Sentinel Network) MASK-Air, initially called Allergy Diary, uses a visual analog scale (VAS) for eye, nose, & asthma symptoms, work impairment, and a global assessment. The data collected by the users of this app have led to new insights on work productivity, treatment patterns, and phenotypes of allergic diseases.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701

TREND: Reagent rental agreements

Reagent rental agreements are sales agreements between end users (such as hospitals and diagnostic laboratories) and allergy diagnostic product manufacturers. Under these agreements, the end user rents or purchases instruments at a subsidized rate by entering into a reagent-purchase contract with the manufacturer. This mutually beneficial agreement lowers the initial capital investment for the end user while assuring the manufacturer of purchases over a substantial time period. In some cases, analyzers are rented out to the end user at a cost-per-test rate.

Reagent rental agreements and cost-per-test contracts provide significant benefits to laboratories focusing on reducing costs. They also help laboratories avoid major fixed capital expenditures associated with the purchase of new equipment. For high-volume laboratories, these expenditures are substantially higher than those of a standard laboratory. Moreover, with the average contract lasting between 5 and 10 years, this allows laboratories to remain updated with the latest innovations in allergy diagnostics. Some contracts also include service/maintenance expenses in the total cost, providing additional savings for laboratories.

Key Developments:

  • In 2021, Hitachi Chemical Diagnostics, Inc. has been renamed Minaris Medical America, Inc. By uniting the medical business group companies under the name of Minaris Medical, Hitachi aims to strengthen its global presence and expand business operations in the field of in-vitro diagnostics. The companies are a part of Showa Denko Materials Co., Ltd. (renamed from Hitachi Chemical Co., Ltd. on Oct 1, 2020).
  • In 2021, PerkinElmer Inc. entered into an agreement with Immunodiagnostic Systems Holdings PLC to acquire the later. The acquisition will enable PerkinElmer Inc. to strengthen its position in the ImmunoDiagnostics (IDS) market. IDS would be incorporated under EUROIMMUN Medizinische LABORDIAGNOSTIKA AG, a company offering allergy products and solutions.
  • In 2020, NEOGEN Corporation launched Reveal 3-D for Gluten
  • In 2019, Romer Labs Division Holding GmbH opened its APAC Solutions Centre in Singapore. The APAC Solutions Centre features new facilities for food allergen testing.
  • In 2018, Omega Diagnostics Group PLC and Immunodiagnostic Systems (IDS) entered into a supply agreement through which Immunodiagnostic Systems (IDS) is the official distributor of allergy tests offered by Omega Diagnostics Group PLC.

Buy Now: https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=232871701

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

sales@marketsandmarkets.com

Related Reports:

Veterinary Vaccines Market: https://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html

Veterinary Diagnostics Market: https://www.marketsandmarkets.com/Market-Reports/veterinary-diagnostics-market-26017452.html

Vaccines Market: https://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html

Immunoassay Market: https://www.marketsandmarkets.com/Market-Reports/immunoassay-market-436.html

In vitro Diagnostics Market: https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html

Comments are closed